Japan's top COVID-19 adviser Omi

**This is a 60-seconds sample of the video. For the full version, please contact us.**

Japan's top COVID-19 adviser Omi

Shigeru Omi, chairman of a government subcommittee on the coronavirus response, holds a press conference at the Cabinet Office in Tokyo on Sept. 8, 2021.

  • Product Code
  • ILEA000732710
  • Registered date
  • 2021/9/08 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • Kyodo News
  • Media size
  • 1920 × 1080 pixel
  • Deployment size
  • 95.95(MB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Ex-Japan top COVID-19 adviser Omi

    Ex-Japan top COVID-19 adviser Omi

    Shigeru Omi reflects on his time as the Japanese government's top COVID-19 adviser during an interview in Tokyo on Sept. 19, 2023.
      Ex-Japan top COVID-19 adviser Omi

      Ex-Japan top COVID-19 adviser Omi

      Shigeru Omi reflects on his time as the Japanese government's top COVID-19 adviser during an interview in Tokyo on Sept. 19, 2023.
        Scene in Osaka

        Scene in Osaka

        Combined photo shows Osaka Castle Park in western Japan during a government stay-at-home request on April 8, 2020, (L) and the same place on May 8, 2023, (R) after coronavirus was reclassified and put in the same category as seasonal flu.
          Scene in Osaka

          Scene in Osaka

          Combined photo shows Osaka's Minami area in western Japan during a government stay-at-home request on April 10, 2020, (top) and the same place on May 8, 2023, (bottom) after coronavirus was reclassified and put in the same category as seasonal flu.
            Scene in Osaka

            Scene in Osaka

            Combined photo shows Osaka Castle Park in western Japan during a government stay-at-home request on April 8, 2020, (L) and the same place on May 8, 2023, (R) after coronavirus was reclassified and put in the same category as seasonal flu.
              Scene in Osaka

              Scene in Osaka

              Combined photo shows Osaka's Minami area in western Japan during a government stay-at-home request on April 10, 2020, (top) and the same place on May 8, 2023, (bottom) after coronavirus was reclassified and put in the same category as seasonal flu.
                Japan's top medical adviser Shigeru Omi

                Japan's top medical adviser Shigeru Omi

                The Japanese government's top medical adviser Shigeru Omi speaks on the new COVID-19 guidelines for mask-wearing at a press conference in Tokyo on Feb. 10, 2023.
                  Japan's top medical adviser Shigeru Omi

                  Japan's top medical adviser Shigeru Omi

                  The Japanese government's top medical adviser Shigeru Omi speaks on the new COVID-19 guidelines for mask-wearing at a press conference in Tokyo on Feb. 10, 2023.
                    China's anti-COVID drug Azvudine

                    China's anti-COVID drug Azvudine

                    Photo taken on Jan. 10, 2023, shows an assembly line for oral anti-COVID drug Azvudine at a factory of China Resources Double-Crane Pharmaceutical Co. in Beijing. The Chinese government unveiled the factory to the media amid rampant coronavirus infections in the country.
                      China's anti-COVID drug Azvudine

                      China's anti-COVID drug Azvudine

                      Photo taken on Jan. 10, 2023, shows an assembly line for oral anti-COVID drug Azvudine at a factory of China Resources Double-Crane Pharmaceutical Co. in Beijing. The Chinese government unveiled the factory to the media amid rampant coronavirus infections in the country.